๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Modified Tumor-free Techniques Operation to Cervical Cancer
NCT06836869Cervical Cancer Stage IB2
Peking Union Medical College Hospital
Not applicable
524
Lanzhou, Guangzhou, Cangzhou, Shijiazhuang, Changsha, Changchun, Shanghai, Xianyang
2025-02-20
Recruiting
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
NCT05798845NSCLC
Shanghai Chest Hospital
Phase 2
124
Shanghai
2025-02-20
Recruiting
Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness
NCT06914583Facial Dryness, Facial Dullness
IBSA Farmaceutici Italia Srl
Not applicable
500
Beijing, Changde, Chengdu, Shanghai, Xi'an
2025-02-19
Active, closed
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
NCT06727565Head and Neck Squamous Cell Carcinoma
Gilead Sciences
Phase 2
39
Chengdu, Hangzhou, Nanning, Shanghai, Wuhan
2025-02-18
Recruiting
JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer
NCT06846437Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
Shanghai JMT-Bio Inc.
Phase 3
228
Shanghai
2025-02-18
Not yet open
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC
NCT06837948Locally Advanced Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
160
Shanghai
2025-02-18
Recruiting
Effect of Low Valine Diet on Body Weight and Metabolic Parameters
NCT06883578Overweight/obesity, Metabolic Associated Fatty Liver Disease, Metabolic Diseases
Shanghai Zhongshan Hospital
Not applicable
48
Shanghai
2025-02-18
Recruiting
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580Oral Microbiota, Pancreatitis, Pancreatic Cancer
Ruijin Hospital
Observational
360
Shanghai
2025-02-18
Recruiting
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
NCT06754930Non-small Cell Lung Cancer (NSCLC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
400
Shanghai
2025-02-18
Recruiting
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
NCT06743945Transformed Lymphoma
Fudan University
Phase 2
20
Shanghai
2025-02-17
Not yet open
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948Generalized Myasthenia Gravis (gMG)
Chongbo Zhao
Phase 1
18
Shanghai
2025-02-15
Not yet open
Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer
NCT06798506TNBC - Triple-Negative Breast Cancer
Fudan University
Observational
300
Shanghai
2025-02-15
Recruiting
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
NCT06738160NSCLC, Stereotactic Body Radiation Therapy (SBRT), Immunotherapy
Fudan University
Phase 2
27
Shanghai
2025-02-15
Not yet open
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
NCT06797622Breast Cancer, Metastatic Breast Cancer
Fudan University
Phase 2
50
Shanghai
2025-02-15
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819Advanced Solid Tumors, HER2 Mutation
Bayer
Phase 2
111
Beijing, Changsha, Shanghai, Hangzhou
2025-02-13
Recruiting
Reverse HER2-negative Immune Resistant Breast Cancer
NCT06731140HER2 Negative Breast Cancer
Fudan University
Phase 2
10
Shanghai
2025-02-12
Recruiting
A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT06718621Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Shanghai
2025-02-12
Recruiting
Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer
NCT07615751Breast Cancer
Fudan University
Phase 3
502
Shanghai
2025-02-12
Recruiting
Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection
NCT06821451Lung Nodules
Ruijin Hospital
Not applicable
80
Shanghai
2025-02-10
Not yet open
Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT06814067Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC
Fudan University
Phase 2
80
Shanghai
2025-02-10
Recruiting
A Study of GC203 TIL in PDCA (RJ)
NCT06828328Pancreatic Cancer, Pancratic Ductal Adenocarcinoma, Treatment Side Effects, Tumor Infiltrating Lymphocytes
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1
10
Shanghai
2025-02-10
Recruiting
The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
NCT06763354Bladder Cancer
RenJi Hospital
Not applicable
20
Shanghai
2025-02-08
Not yet open
Clinical Classification of MAFLD Based Liver Biopsy
NCT06795646Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital
Observational
2,000
Beijing, Hangzhou, Shanghai, Tianjin
2025-02-08
Active, closed
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236Platinum-resistant Ovarian Cancer
Genmab
Phase 3
530
Guangzhou, Xi'an, Changchun, Hanzhou, Shanghai, Tianjin, Zhengzhou
2025-02-07
Recruiting
Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations
NCT07117890Non Small Cell Lung Cancer
Fudan University
Phase 2
34
Shanghai
2025-02-07
Recruiting
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
NCT06758700Extensive-stage Small Cell Lung Cancer (ES-SCLC), Thoracic Neoplasms, Lung Neoplasms, Lung Diseases
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
15
Shanghai
2025-02-07
Recruiting
RTMS for CHR Based on Personalized Targets Using Magnetoencephalography
NCT06802952Clinical High-risk Syndrome of Psychosis
Shanghai Mental Health Center
Not applicable
26
Shanghai
2025-02-07
Recruiting
Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG
NCT06796725Migraine Disorders, Brain, rTMS Stimulation
Ruijin Hospital
Not applicable
60
Shanghai
2025-02-06
Recruiting
Influence of Healing Time on the Outcomes of Alveolar Ridge Preservation in Periodontally Compromised Extraction Sockets
NCT06654141Tooth Loss
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
42
Shanghai
2025-02-06
Not yet open
Study on the Correlation Between Tracheotomy Tip Pressure and Esophageal Pressure in Patients Weaned from Tracheotomy
NCT06783777Respiratory Distress Syndrome (RDS), Respiratory Ilness
Shanghai Zhongshan Hospital
Not applicable
42
Shanghai
2025-02-05
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
NCT06624670Pyoderma Gangrenosum
LEO Pharma
Phase 3
90
Beijing, Changchun, Changsha, Chengdu, Hangzhou, Jinan, Shanghai, Shenzhen
2025-02-05
Recruiting
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
NCT06752811Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd.
Phase 3
416
Nanjing, Shanghai
2025-02-05
Recruiting
RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography
NCT06802939Refractory Auditory Hallucinations, Schizophrenia
Shanghai Mental Health Center
Not applicable
36
Shanghai
2025-02-05
Recruiting
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
NCT06756932Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer
BeOne Medicines
Phase 1
120
Guangzhou, Zhengzhou, Shanghai, Tianjin, Hangzhou
2025-02-04
Recruiting
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
NCT06601075Advanced Colorectal Cancer
Ruijin Hospital
Observational
30
Shanghai
2025-02-01
Recruiting
Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus
NCT06821399Diabetes, Diabetic Retinopathy, Type 2 Diabetes Mellitus (T2DM)
Yufan Wang
Observational
2,920
Lanzhou, Shanghai, Shenyang
2025-02-01
Not yet open
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
NCT06794710Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy, Restrictive Cardiomyopathy
RenJi Hospital
Not applicable
300
Shanghai
2025-02-01
Recruiting
RCT of EFTR Versus STER for GIST Treatment
NCT07411118Small Size Gastrointestinal Stromal Tumors, GIST
Chinese University of Hong Kong
Not applicable
136
Shanghai
2025-02-01
Recruiting
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
NCT06964568Esophageal Carcinoma, Radiotherapy, Immunotherapy
Fudan University
Phase 3
452
Shanghai
2025-02-01
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
NCT06798077Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
China-Japan Friendship Hospital
Observational
2,000
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Shenyang, Xi'an, Shanghai
2025-02-01
Recruiting
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
NCT06800768Thyroid Cancer
Ruijin Hospital
Observational
40
Shanghai
2025-02-01
Active, closed
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414Myopia Progressing
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
40
Shanghai
2025-02-01
Recruiting
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025Asthma
Beijing Chao Yang Hospital
Not applicable
200
Beijing, Guangzhou, Zhengzhou, Changsha, Shenyang, Shanghai, Taiyuan, Hangzhou
2025-02-01
Not yet open
Avapritinib Maintenance for AML With KIT Mutations
NCT06765915AML, Adult
Ruijin Hospital
Phase 2
47
Shanghai
2025-02-01
Active, closed
A Study on the Changes and Prognosis of Intestinal Microbiota and Function in Infants With Food Allergies
NCT06854536Health, Children, Gut Microbiota
Ruijin Hospital
Observational
100
Shanghai
2025-02-01
Not yet open
Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).
NCT06844773Unresectable Locally Advanced Pancreatic Cancer
Shanghai Zhongshan Hospital
Observational
36
Shanghai
2025-02
Not yet open
Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures
NCT06762704The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,408
Hefei, Nanjing, Nanchang, Xi'an, Shanghai
2025-02
Not yet open
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
NCT06833307Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
90
Beijing, Shanghai
2025-02
Not yet open
Effect of Food and Age on the Pharmacokinetics of LY03017
NCT06793995Alzheimer's Disease Psychosis, Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
Luye Pharma Group Ltd.
Phase 1
26
Shanghai
2025-02
Not yet open
Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
NCT06777810Diabetic Foot Disease, Diabetic Foot Ulcer, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-01-31
Recruiting
Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer
NCT06818149Lung Cancer, Myocarditis Due to Drug
Shanghai Chest Hospital
Observational
50
Shanghai
2025-01-30
Not yet open
Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC
NCT06768255Abiraterone Acetate, MCRPC (metastatic Castration-resistant Prostate Cancer)
Ding-Wei Ye
Phase 3
400
Shanghai
2025-01-30
Active, closed
FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan
NCT07356388Kidney Transplantation Recipients, Proteinuria Patients
kewen Chen,MD
Phase 3
54
Shanghai
2025-01-30
Recruiting
Nomogram for Predicting Difficult Laparoscopic Appendectomy
NCT06818942Emergencies
Shanghai 6th People's Hospital
Observational
500
Shanghai
2025-01-26
Recruiting
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
NCT07342803Allergic Asthma
Longbio Pharma
Phase 2
200
Shanghai
2025-01-25
Recruiting
Clinical Study of U01๏ผˆssCART-19๏ผ‰ in Patients With B-Cell Lymphoma
NCT07093073B Cell Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1
30
Shanghai
2025-01-23
Recruiting
MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL
NCT06793189Marginal Zone Lymphoma(MZL)
Ruijin Hospital
Phase 2
145
Shanghai, Shenyang, Beijing
2025-01-23
Recruiting
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
NCT06698796Dermatomyositis, Polymyositis
Pfizer
Phase 3
211
Hefei, Nanchang, Shanghai, Kunming, Beijing
2025-01-22
Active, closed
Vorasidenib in Combination With Temozolomide (TMZ) in IDH-mutant Glioma
NCT06478212IDH1-mutant Glioma, IDH2-mutant Glioma
Institut de Recherches Internationales Servier
Phase 1/2
51
Beijing, Shanghai
2025-01-22
Recruiting
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
NCT06737731Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
300
Shanghai
2025-01-21
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses
NCT06693362Severe Viral Pneumonia(Not Include COVID-19)
Ruijin Hospital
Phase 1
60
Shanghai
2025-01-20
Recruiting
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
NCT06963320Circulatory Disease
Livzon Pharmaceutical Group Inc.
Phase 2
320
Shanghai
2025-01-20
Active, closed
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
NCT06512337Plaque Psoriasis
Bristol-Myers Squibb
Observational
153
Guangzhou, Handan, Dalian, Shanghai, Beijing
2025-01-20
Recruiting
Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia
NCT06689514Prostatic Hypertrophy, Benign
Yifeng Jing
Phase EARLY_PHASE1
30
Shanghai
2025-01-20
Recruiting
Comparing Super Pulse Fiber Thulium Laser and Holmium Laser for Ureteral Stone Fragmentation During Ureteroscopy
NCT06667557Kidney Calculi
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
136
Shanghai
2025-01-20
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Guangzhou, Shanghai
2025-01-20
Recruiting
A Study of Chinese Congenital Bicuspid Aortic Valve
NCT06802016Bicuspid Aortic Valve (BAV)
Ruijin Hospital
Observational
500
Shanghai
2025-01-18
Recruiting
Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue
NCT07656324Cancer
Fudan University
Observational
1,000,000
Shanghai
2025-01-17
Active, closed
Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus
NCT06587438Diabetes Mellitus
Sinocare
Not applicable
160
Beijing, Chongqing, Shunde, Wuhan, Jinan, Shanghai
2025-01-17
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
Study on the Mechanism of Acquired Resistance of Entrectinib
NCT07199959ROS1 Fusion Positive, Non Small Cell Lung Cancer
Fudan University
Observational
38
Shanghai
2025-01-15
Recruiting
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
NCT06775743NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Fudan University
Phase 2
53
Shanghai
2025-01-15
Not yet open
Capecitabine in Low Risk Triple Negative Breast Cancer
NCT06787339Breast Cancer
Fudan University
Phase 2
198
Shanghai
2025-01-15
Not yet open
Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)
NCT06765525Hip Dysplasia, Developmental
RenJi Hospital
Not applicable
1,976
Shanghai
2025-01-15
Recruiting
Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
NCT06731868Tardive Dyskinesia (TD)
Luye Pharma Group Ltd.
Phase 1/2
120
Shanghai
2025-01-14
Recruiting
Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation
NCT06515132Disorder of Consciousness, Spinal Cord Stimulation
Huashan Hospital
Not applicable
50
Fuzhou, Changsha, Shanghai
2025-01-10
Recruiting
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
NCT06349408Locally Advanced Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
250
Beijing, Shanghai, Hangzhou
2025-01-10
Active, closed
Performance Evaluation of Artificial Intelligence Screening Model in Coronary Heart Disease Detection
NCT06658600Coronary Heart Disease
Tsinghua University
Not applicable
900
Beijing, Shanghai
2025-01-10
Recruiting
Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs
NCT06754956High Resolution Vessel Wall Imaging, Intracranial Atherosclerotic Stenosis, ICAS, Arteriosclerosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not applicable
100
Shanghai
2025-01-10
Recruiting
AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
NCT06766422Unruptured Cerebral Aneurysm, Artificial Intelligence (AI), Subarachnoid Hemorrhage, Aneurysmal, Magnetic Resonance Angiography
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
10,000
Shanghai
2025-01-10
Recruiting
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
NCT07538128Recurrent Glioblastoma
Huashan Hospital
Phase EARLY_PHASE1
10
Shanghai
2025-01-09
Recruiting
A Study of SHR-4375 in Subjects With Solid Tumors
NCT06764628Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
208
Shanghai
2025-01-09
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors
NCT06772415Advanced Solid Tumor
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Recruiting
Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis
NCT06718933Breast Cancer Metastatic, Breast Cancer Brain Metastases
Fudan University
Phase 1/2
74
Shanghai
2025-01-08
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT06712316Non-small Cell Lung Cancer
BioNTech SE
Phase 2/3
1,580
Baoding, Beijing, Changchun, Hangzhou, Jinan, Kunming, Nanjing, Shanghai
2025-01-07
Recruiting
A Phase โ…  Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors
NCT07229898Advanced Solid Tumors
Henan Genuine Biotech Co., Ltd.
Phase 1
48
Harbin, Jinan, Shanghai, Xinxiang
2025-01-07
Recruiting
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586Antiphospholipid (aPL)-Positive, Thrombocytopaenia
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, รœrรผmqi, Wenzhou, Beijing, Shanghai
2025-01-07
Active, closed
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)
NCT06660654Advanced Solid Tumor, Metastatic Solid Tumors
Daiichi Sankyo
Phase 2
200
Changsha, Shanghai
2025-01-06
Recruiting
Assessing the Prevalence and Epidemiological Characteristics of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Autoimmune Gastritis(AIG) Through Hydrogen and Methane Breath Testing(HMBT).
NCT06946706Autoimmune Gastritis
RenJi Hospital
Observational
220
Shanghai
2025-01-06
Recruiting
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
NCT06754371Postpartum Hemorrhage, Systemic Autoimmune Diseases
RenJi Hospital
Phase 4
276
Shanghai
2025-01-06
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
NCT06375005Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Active, closed
Social Cognition in Children and Adolescents With Autism Spectrum Disorder
NCT07692022Autism
Children's Hospital of Fudan University
Observational
1,000
Shanghai
2025-01-05
Recruiting
Pancreatic Cancer and Diabetes Mellitus
NCT06585072Pancreatic Cancer, Surgery, Diabetes Mellitus
Shanghai Changzheng Hospital
Observational
150
Shanghai
2025-01-03
Recruiting
Dupilumab Therapy for EGIDs
NCT07257835Eosinophilic Gastrointestinal Disorders (EGIDs)
Children's Hospital of Fudan University
Observational
20
Shanghai
2025-01-01
Not yet open
Evaluate the Efficacy of Radiofrequency Ablation/Vertebroplasty with or Without SBRT for Treating Painful Spinal Vertebral Metastases
NCT06756087Spinal Metastases, Local Control, Pain Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
120
Shanghai
2025-01-01
Recruiting
Postoperative Rotational Dynamics of Three Toric Intraocular Lens Designs
NCT07453992Cataract
Jin Yang
Not applicable
400
Shanghai
2025-01-01
Recruiting
Combined Coronary CT Angiography and CT Perfusion in Coronary Artery Disease (CoroFusion)
NCT06949150Coronary Arterial Disease (CAD)
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-01-01
Active, closed
Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer
NCT07312500Gastric (Stomach) Cancer
Fudan University
Observational
3,000
Shanghai
2025-01-01
Not yet open
Comparative Efficacy and Safety of Extensive Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequency Ablation in Persistent Atrial Fibrillation
NCT06745167Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
600
Shanghai
2025-01-01
Not yet open
Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
NCT06765928MDS, AML, Adult
Ruijin Hospital
Phase 2
73
Shanghai
2025-01-01
Rows per page Showing 1801–1900 of 3827
Previous 17 18 19 20 21 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=19

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.